QVMT Invesco S&P 500 Concentrated QVM ETF

Expense Ratio
0.13%
Dividend
2.28%
Previous close
$60.05
Est. 12 months change
+10.08%
Projected Price
$66.10

Profitability Metrics

Return on Equity (ROE)
47.09%
Return on Assets (ROA)
9.98%
Return on Invested Capital (ROIC)
31.39%
Weighted Average Cost of Capital (WACC)
8.52%
ROIC - WACC
22.87%
Updated : 2026-04-04 07:12 ET

Valuation Metrics

P/E Ratio
23.26
Forward P/E
19.33
PEG Ratio
2.16
Debt Current Ratio
1.27

Growth & Cash Flow

Gross Margin
47.29%
Operating Margin
24.79%
FCF Margin
20.89%
TTM Revenue Growth
10.13%
Projected 12M EPS Growth
20.37%

Price Change

Price % from 50 SMA
-0.28%
Price % from 200 SMA
7.52%
6 Months
10.08%
1 Year
15.48%
2 Years
21.44%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
JNJ5.47%
NFLX4.96%
V4.61%
AAPL4.47%
WMT4.42%
MA4.23%
GE3.83%
CVX3.77%
LRCX3.22%
CSCO3.08%

ETF Analysis

Fund Overview

Invesco S&P 500 Concentrated QVM ETF (QVMT) currently reports 100 stock positions (subject to change), placing it in the moderately diversified range by holdings breadth. The top line-up is JNJ (5.47%), NFLX (4.96%), V (4.61%), with JNJ as the largest single weight at 5.47%. Together, the top three holdings account for 15.04%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 31.39%, WACC is 8.52%, and the economic spread is 22.87%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 47.09% and ROA at 9.98%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 23.26, forward P/E of 19.33, PEG of 2.16. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A PEG in this range suggests valuation is fair rather than compelling — the portfolio is priced adequately for its growth, with limited buffer for downside revisions. At 1.27, the aggregate current ratio reflects holdings with limited near-term liquidity buffer. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 47.29%, operating margin at 24.79%, and free cash flow margin at 20.89%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. Operating margins sit in a healthy range — not exceptional, but indicating reasonable operational efficiency. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

Growth & Forward Outlook

The two main inputs to the near-term picture — TTM revenue growth of 10.13% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 20.4% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue momentum establishes the baseline; analyst price targets reveal how much the market is already paying for future execution on top of that baseline. Delivered returns will ultimately be shaped by the gap — or lack thereof — between operating execution and the expectations embedded in current prices. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.